CD46 in Meningococcal Disease
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
The human-specific bacterial pathogen Neisseria meningitidis is a major cause of sepsis and/or meningitis. The pili of N. meningitidis interact with CD46, a human cell-surface protein involved in regulation of complement activation. Transgenic mice expressing human CD46 were susceptible to meningococcal disease, because bacteria crossed the blood-brain barrier in these mice. Development of disease was more efficient with piliated bacteria after intranasal, but not intraperitoneal, challenge of CD46 transgenic mice, suggesting that human CD46 facilitates pilus-dependent interactions at the epithelial mucosa. Hence, the human CD46 transgenic mice model is a potentially useful tool for studying pathogenesis and for vaccine development against meningococcal disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“To date, few humanized mouse models have been established that exploit non-immune host factors (Johansson et al., 2003; Lecuit et al., 2001; Sun et al., 2004).”
From Specificity for human hemoglobin enhances Staphylococcus aureus infection (2010) · cites this paper as Johansson et al., 2003
Citations
Cites
Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes
Studier, F. W., & Moffatt, B. A. (1986) · Journal of Molecular Biology · doi:10.1016/0022-2836(86)90385-2 · Cited by 6,320
(1961) · Elsevier eBooks · doi:10.1016/b978-0-12-395584-5.x5001-x · Cited by 1,609
The human CD46 molecule is a receptor for measles virus (Edmonston strain)
Dörig, R. E., Marcil, A., Chopra, A., & Richardson, C. D. (1993) · Cell · doi:10.1016/0092-8674(93)80071-l · Cited by 1,033
Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus
Naniche, D., Varior-Krishnan, G., Cervoni, F., Wild, T. F., Rossi, B., Rabourdin-Combe, C., & Gerlier, D. (1993) · Journal of Virology · doi:10.1128/jvi.67.10.6025-6032.1993 · Cited by 853
Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains.
Adams, J. C. (1992) · Journal of Histochemistry & Cytochemistry · doi:10.1177/40.10.1527370 · Cited by 641
CD46 Is a Cellular Receptor for Human Herpesvirus 6
Santoro, F., Kennedy, P. E., Locatelli, G., Malnati, M. S., Berger, E. A., & Lusso, P. (1999) · Cell · doi:10.1016/s0092-8674(00)81678-5 · Cited by 522
Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria
Källström, H., Liszewski, M. K., Atkinson, J. P., & Jonsson, A. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.4841857.x · Cited by 358
Self-citationInteractions of Pathogenic Neisseriae with Epithelial Cell Membranes
Merz, A. J., & So, M. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.423 · Cited by 318
Phase variation of gonococcal pili by frameshift mutation in pilC, a novel gene for pilus assembly.
Jonsson, A. B., Nyberg, G., & Normark, S. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07970.x · Cited by 296
Self-citationOkada, N., Liszewski, M. K., Atkinson, J. P., & Caparon, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2489 · Cited by 290
Research works printed but not linked: 1
- C. Kemper et al., Clin. Exp. Immunol.124, 180 (2001).
Cited by
Pili in Gram-negative and Gram-positive bacteria — structure, assembly and their role in disease
Proft, T., & Baker, E. N. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8477-4 · Cited by 547
Mechanisms of microbial traversal of the blood–brain barrier
Kim, K. S. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1952 · Cited by 466
“fcgi?db=protein&id=83616361">NadA ) and the Opa and Opc protein”
Acute bacterial meningitis in infants and children
Kim, K. S. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70306-8 · Cited by 454
Veerhuis, R., Nielsen, H. M., & Tenner, A. J. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.04.003 · Cited by 419
“For example the meningitis causing bacteria Neisseria meningitidis invades the CNS through the nasopharyngeal mucosa and uses the membrane bound Creg CD46 which interacts with bacterial pili, to cross the blood-brain-barrier (Johansson et al., 2003).”
BackgroundPlasminogen is a critical host pathogenicity factor for group A streptococcal infection
Sun, H., Ringdahl, U., Homeister, J. W., Fay, W. P., Engleberg, N. C., Yang, A. Y., Rozek, L. S., Wang, X., Sjöbring, U., & Ginsburg, D. (2004) · Science · doi:10.1126/science.1101245 · Cited by 408
Neisseria meningitidis: an overview of the carriage state
Yazdankhah, S. P., & Caugant, D. A. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45529-0 · Cited by 379
“The strains comprised 71 different sequence types (STs), which were assigned to 34 different complexes or lineages (Jolley et al., 2000).”
BackgroundMeningococcal disease and the complement system
Lewis, L. A., & Ram, S. (2014) · Virulence · doi:10.4161/viru.26515 · Cited by 227
“In one study, a small increase in mortality was seen when human CD46 transgenic mice were challenged intranasally with piliated meningococci while animals challenged with nonpiliated bacteria showed 100% survival.(203) In separate experiments where bacteria were administered intraperitoneally, mice expressing human CD…”
BackgroundSensing Gram-Negative Bacterial Lipopolysaccharides: a Human Disease Determinant?
Munford, R. S. (2008) · Infection and Immunity · doi:10.1128/iai.00939-07 · Cited by 189
“do capsule, LPS sialylation, and pili play in this process (65)?”
BackgroundIdentification of Common Genetic Variation That Modulates Alternative Splicing
Hull, J., Campino, S., Rowlands, K., Chan, M.-S., Copley, R. R., Taylor, M. S., Rockett, K., Elvidge, G., Keating, B., Knight, J., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030099 · Cited by 157
“CD46 is a cellsurface glycoprotein involved in regulation of complement activation and it acts as a receptor for several pathogens including measles virus, Streptococcus pyogenes, Neisseria gonorrhea, and Neisseria meningitidis [25].”
Mairey, E., Genovesio, A., Donnadieu, E., Bernard, C., Jaubert, F., Pinard, E., Seylaz, J., Olivo-Marin, J.-C., Nassif, X., & Duménil, G. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060482 · Cited by 184
“Mice expressing human CD46 have been described as a model for meningococcemia (18), but the role of CD46 in meningococcal adhesion is under discussion (32, 33) making this model inappropriate for this study.”
BackgroundInteractions between Neisseria meningitidis and the complement system
Schneider, M. C., Exley, R. M., Ram, S., Sim, R. B., & Tang, C. M. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2007.03.005 · Cited by 181
CD46: expanding beyond complement regulation
Riley-Vargas, R. C., Gill, D. B., Kemper, C., Liszewski, M. K., & Atkinson, J. P. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.07.004 · Cited by 178
Thanassi, D. G., Bliska, J. B., & Christie, P. J. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2012.00342.x · Cited by 172
“CD46 has been identified as a pilus receptor and transgenic mice expressing human CD46 are susceptible to infection by piliated N. meningitidis (Johansson et al., 2003).”
BackgroundNeisseria gonorrhoeae: Drug Resistance, Mouse Models, and Vaccine Development
Rice, P. A., Shafer, W. M., Ram, S., & Jerse, A. E. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090816-093530 · Cited by 171
“Some restrictions can be alleviated by transgenic (Tg) mice that express human carcinoembryonic antigen cellular adhesion molecules (CEACAMs; 108), human CD46 (55), human transferrin (133), and human FH and C4BP (29, 67).”
BackgroundHauwel, M., Furon, E., Canova, C., Griffiths, M., Neal, J. W., & Gasque, P. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.012 · Cited by 167
Granoff, D. M., Welsch, J. A., & Ram, S. (2009) · Infection and Immunity · doi:10.1128/iai.01191-08 · Cited by 161
Estradiol-Treated Female Mice as Surrogate Hosts for Neisseria gonorrhoeae Genital Tract Infections
Jerse, A. E., Wu, H., Packiam, M., Vonck, R. A., Begum, A. A., & Garvin, L. E. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00107 · Cited by 140
“Russell and meningococcal dissemination to the brain following intranasal or intraperitoneal inoculation and induce higher levels of cytokines (Johansson et al., 2003, 2005).”
BackgroundSpecificity for human hemoglobin enhances Staphylococcus aureus infection
Pishchany, G., McCoy, A. L., Torres, V. J., Krause, J. C., Crowe, J. E., Fabry, M. E., & Skaar, E. P. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.11.002 · Cited by 146
“To date, few humanized mouse models have been established that exploit nonimmune host factors (Johansson et al., 2003; Lecuit et al., 2001; Sun et al., 2004).”
BackgroundNgampasutadol, J., Ram, S., Gulati, S., Agarwal, S., Li, C., Visintin, A., Monks, B., Madico, G., & Rice, P. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3426 · Cited by 123
“meningitidis invade the CNS more readily in human CD46-transgenic mice (73), although the complement regulatory function of this protein has not been specifically implicated in this enhanced susceptibility.”
BackgroundKirchner, M., Heuer, D., & Meyer, T. F. (2005) · Infection and Immunity · doi:10.1128/iai.73.5.3072-3082.2005 · Cited by 128
“challenge with Neisseria meningitidis (13); however, bacteremia and mortality were not restricted to pilus-producing strains.”
BackgroundInfluentialMelican, K., Veloso, P. M., Martin, T., Bruneval, P., & Duménil, G. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003139 · Cited by 126
“Several attempts have been made to generate in vivo models of Neisseria meningitidis infection; each producing important advances [24,27,28], but lacking crucial aspects of the development of Figure 3.”
BackgroundMeningococcal interactions with the host
Carbonnelle, É., Hill, D. J., Morand, P., Griffiths, N. J., Bourdoulous, S., Murillo, I., Nassif, X., & Virji, M. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.069 · Cited by 122
CD46: The ‘multitasker’ of complement proteins
Yamamoto, H., Fara, A. F., Dasgupta, P., & Kemper, C. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.09.016 · Cited by 116
“…also use CD46 s receptor and signalling events mediated by this interaction have een shown to support entry of the bacteria into epithelial cells as ell as transgression of the microbe through the blood-brain barier (Lee et al., 2002; Johansson et al., 2003; Gill and Atkinson, 2004; ussell, 2004).”
BackgroundCD46 in innate and adaptive immunity: an update
Cardone, J., Le Friec, G., & Kemper, C. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04400.x · Cited by 98
Emerging roles and new functions of CD46
Liszewski, M. K., Kemper, C., Price, J. D., & Atkinson, J. P. (2005) · Springer Seminars in Immunopathology · doi:10.1007/s00281-005-0002-3 · Cited by 108
“Infection of CD46 transgenic mice with Neisseria meningitis produced bacteremia and more efficient penetration of the blood–brain barrier [30].”
BackgroundNi, S., Bernt, K. M., Gaggar, A., Li, Z.-Y., Kiem, H., & Lieber, A. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.664 · Cited by 108
Abnormal Tr1 differentiation in multiple sclerosis
Astier, A., & Hafler, D. A. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.09.018 · Cited by 100
“analyzed the infection of human CD46expressing transgenicmice byNeisseriameningitides, the causative agent of meningococcal meningitis (Johansson et al., 2003), which binds to CD46 (Kallstrom et al.”
BackgroundBinker, M. G., Cosen-Binker, L. I., Terebiznik, M. R., Mallo, G. V., McCaw, S. E., Eskelinen, E.-L., Willenborg, M., Brumell, J. H., Saftig, P., Grinstein, S., et al. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00946.x · Cited by 76
“These Gram-negative bacteria initially attach to the urogenital mucosa via the bacterial type IV pilus (Merz et al., 2000; Johansson et al., 2003), followed by tight secondary interactions mediated by binding to one of several different host cellular receptors, including the heparan sulfate…”
BackgroundNgampasutadol, J., Ram, S., Blom, A. M., Jarva, H., Jerse, A. E., Lien, E., Goguen, J. D., Gulati, S., & Rice, P. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506471102 · Cited by 98
Molecular basis of host specificity in human pathogenic bacteria
Pan, X., Yang, Y., & Zhang, J. (2014) · Emerging Microbes & Infections · doi:10.1038/emi.2014.23 · Cited by 98
Transgenic mice expressing human transferrin as a model for meningococcal infection
Zarantonelli, M.-L., Szatanik, M., Giorgini, D., Hong, E., Huerre, M., Guillou, F., Alonso, J.-M., & Taha, M.-K. (2007) · Infection and Immunity · doi:10.1128/iai.00781-07 · Cited by 97
“This model represents a substantial improvement as bacteria can cross the blood-brain barrier (BBB) after both intraperitoneal and intranasal infection without addition of iron resources (13, 24).”
Backgroundde Klerk, N., Maudsdotter, L., Gebreegziabher, H., Saroj, S. D., Eriksson, B., Eriksson, O. S., Roos, S., Lindén, S. K., Sjölinder, H., & Jonsson, A. (2016) · Infection and Immunity · doi:10.1128/iai.00163-16 · Cited by 94
Self-citationHansen, J. K., & Forest, K. T. (2006) · Microbial Physiology · doi:10.1159/000094054 · Cited by 93
“CD46 has been implicated as the PilC receptor, although this result remains controversial [Johansson et al., 2003; Kallstrom et al., 1997; Kirchner and Meyer, 2005; Kirchner et al., 2005].”
ResultResistance of Neisseria Gonorrhoeae to Neutrophils
Johnson, M. B., & Criss, A. K. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00077 · Cited by 93
“Inbred mice that are transgenic for human carcinoembryonic antigenrelated cellular adhesion molecules (CEACAMs) and CD46, receptors that are implicated in gonorrheal pathogenesis (Merz and So, 2000), have already been developed (Johansson et al., 2003; Gu et al., 2010), with additional mouse strains likely to be produ…”
Plant, L., Sundqvist, J., Zughaier, S. M., Lövkvist, L., Stephens, D. S., & Jonsson, A. (2006) · Infection and Immunity · doi:10.1128/iai.74.2.1360-1367.2006 · Cited by 92
“A mouse model of meningococcal infection (9, 10) was”
BackgroundMethodSelf-citationGain-of-function experiments: time for a real debate
Duprex, W. P., Fouchier, R. A. M., Imperiale, M. J., Lipsitch, M., & Relman, D. A. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3405 · Cited by 89
Ligand Binding Determines Whether CD46 Is Internalized by Clathrin-coated Pits or Macropinocytosis
Crimeen‐Irwin, B., Ellis, S. L., Christiansen, D., Ludford‐Menting, M., Milland, J., Lanteri, M. B., Loveland, B. E., Gerlier, D., & Russell, S. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308261200 · Cited by 89
Lee, H. S. W., Boulton, I. C., Reddin, K. M., Wong, H., Halliwell, D., Mandelboim, O., GORRINGE, A. R., & Gray‐Owen, S. D. (2007) · Infection and Immunity · doi:10.1128/iai.00222-07 · Cited by 89
“Regardless of the species, Neisseria bacteria attach to the apical surfaces of mucosal epithelial cells via their pili (23).”
BackgroundOlfactory Nerve—A Novel Invasion Route of Neisseria meningitidis to Reach the Meninges
Sjölinder, H., & Jonsson, A.-B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014034 · Cited by 78
“The human cell surface receptor CD46 transgenic mouse model (CD46) has been demonstrated to mimic many aspects of meningococcal disease in humans [13,14,15].”
BackgroundSelf-citationA regulatory role for macrophage class A scavenger receptors in TLR4‐mediated LPS responses
Chen, Y., Wermeling, F., Sundqvist, J., Jonsson, A., Tryggvason, K., Pikkarainen, T., & Karlsson, M. C. I. (2010) · European Journal of Immunology · doi:10.1002/eji.200939891 · Cited by 79
Self-citationThe Biology of Neisseria Adhesins
Hung, M.-C., & Christodoulides, M. (2013) · Biology · doi:10.3390/biology2031054 · Cited by 79
“also demonstrated that transgenic mice expressing human CD46 are susceptible to meningococcal infection [204].”
BackgroundPathogen translocation across the blood-brain barrier
Pulzová, L., Bhide, M. R., & Kováč, A. (2009) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2009.00594.x · Cited by 77
Sjölinder, H., Eriksson, J., Maudsdotter, L., Aro, H., & Jonsson, A. (2008) · Infection and Immunity · doi:10.1128/iai.00478-08 · Cited by 77
“infection with piliated meningococci caused lethal disease in 15% of the mice, whereas nonpiliated bacteria did not cause disease (18, 19).”
BackgroundSelf-citationIn Vivo Adaptation and Persistence of Neisseria meningitidis within the Nasopharyngeal Mucosa
Johswich, K. O., McCaw, S. E., Islam, E. A., Sintsova, A., Gu, A., Shively, J. E., & Gray‐Owen, S. D. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003509 · Cited by 76
“meningitidis in the mouse [3,4,5,6,7,8], the strict specificity of neisserial virulence factors precludes them from reproducing the intimate association of Nme with human mucosal tissues.”
BackgroundChen, Y., Sjölinder, M., Wang, X., Altenbacher, G., Hagner, M., Berglund, P., Gao, Y., Lu, T., Jonsson, A.-B., & Sjölinder, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041445 · Cited by 70
“meningitidis infection, we used a mouse model of meningococcal disease [34,35].”
MethodResultSelf-citationKirchner, M., & Meyer, T. F. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04600.x · Cited by 72
Neisseria models of infection and persistence in the upper respiratory tract
Weyand, N. J. (2017) · Pathogens and Disease · doi:10.1093/femspd/ftx031 · Cited by 72
“Mice expressing human CD46 were used for the study of Nme infection in 2003 (Johansson et al. 2003).”
BackgroundMethodMechanisms of host adaptation by bacterial pathogens
Barber, M. F., & Fitzgerald, J. R. (2024) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuae019 · Cited by 71
“…of the respiratory epithelium (Zhang et al. 2000 , Elm et al. 2004 ), as well as multiple pathogens that engage in species-specific interactions with host CD46 in the r espir atory tr act and skin (Okada et al. 1995 , Johansson et al. 2003 , 2005 , Lövkvist et al. 2008 , Matsui et al. 2009 ).”
BackgroundRussell, S. M. (2004) · Tissue Antigens · doi:10.1111/j.1399-0039.2004.00277.x · Cited by 70
Fimbriae, Pili, Flagella and Bacterial Virulence
Jonsson, A.-B., Normark, S. J., & Rhen, M. (2004) · KARGER eBooks · doi:10.1159/000081690 · Cited by 69
Self-citationExley, R. M., Wu, H., Shaw, J. G., Schneider, M. C., Smith, H. C., Jerse, A. E., & Tang, C. M. (2006) · Infection and Immunity · doi:10.1128/iai.01530-06 · Cited by 65
“While several host-specific features may limit the capacity of mice to completely mimic the human infection (20, 29), there are many physiological similarities between the lower genital tracts of female mice and women, including the presence of commensal lactobacilli and mixed carbon sources for the gonococcus (Table…”
BackgroundJen, F. E. C., Warren, M. J., Schulz, B. L., Power, P. M., Swords, W. E., Weiser, J. N., Apicella, M. A., Edwards, J. L., & Jennings, M. P. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003377 · Cited by 59
“Previous invasion data had implicated CD46 as the pilus receptor for the pathogenic Neisseria [40].”
InfluentialLécuyer, H., Nassif, X., & Coureuil, M. (2011) · Infection and Immunity · doi:10.1128/iai.05837-11 · Cited by 64
“This is consistent with previous data reporting the role of CD46 or I-domaincontaining integrins as an adhesion receptor for type IV pili (5, 9).”
ResultT‐cell regulation by CD46 and its relevance in multiple sclerosis
Astier, A. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02821.x · Cited by 63
Johnson, S., Tan, L., van der Veen, S., Caesar, J. J. E., de Jorge, E. G., Harding, R., Bai, X., Exley, R. M., Ward, P. N., Ruivo, N., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002981 · Cited by 63
“For instance, introducing single amino acid changes into murine molecules [32] or transgenes encoding complete cellular receptors or nutritional sources [33,34] have allowed the study of human-specific pathogens in rodents.”
T-Cell Stimulation and Regulation: With Complements from CD46
Kemper, C., Verbsky, J. W., Price, J. D., & Atkinson, J. P. (2005) · Immunologic Research · doi:10.1385/ir:32:1-3:031 · Cited by 63
Complement Control Protein Modules in the Regulators of Complement Activation
Soares, D. C., & Barlow, P. N. (2005) · CRC Press eBooks · doi:10.1201/9780849350368-2 · Cited by 59
Adenovirus vectors in hematopoietic stem cell genome editing
Li, C., & Lieber, A. (2019) · FEBS Letters · doi:10.1002/1873-3468.13668 · Cited by 58
The Isolated Brain Microvessel: A Versatile Experimental Model of the Blood-Brain Barrier
Pardridge, W. M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00398 · Cited by 50
Quality-control issues and approaches in vaccine development
Metz, B., van den Dobbelsteen, G., van Els, C. A. C. M., van der Gun, J., Levels, L., van der Pol, L., Rots, N. Y., & Kersten, G. F. A. (2009) · Expert Review of Vaccines · doi:10.1586/14760584.8.2.227 · Cited by 54
Mechanisms of meningococcal colonisation
Trivedi, K., Tang, C. M., & Exley, R. M. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.06.006 · Cited by 53
Invasive Potential of Nonencapsulated Disease Isolates of Neisseria meningitidis
Johswich, K. O., Zhou, J., Law, D. K. S., Michael, F. S., McCaw, S. E., Jamieson, F., Cox, A. D., Tsang, R. S. W., & Gray‐Owen, S. D. (2012) · Infection and Immunity · doi:10.1128/iai.00293-12 · Cited by 52
“N. meningitidis is a human-restricted pathogen that specifically interacts with human-derived forms of host proteins, such as transferrin (29), factor H (10), carcinoembryonic antigen-like cell adhesion molecules (11), and CD46 (16), allowing important functions, such as the acquisition of iron, evasion of complement…”
BackgroundOuter membrane vesicles of Neisseria lactamica as a potential mucosal adjuvant
Sardiñas, G., Reddin, K. M., Pajón, R., & GORRINGE, A. R. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.07.064 · Cited by 52
Welsch, J. A., & Granoff, D. M. (2004) · Infection and Immunity · doi:10.1128/iai.72.10.5903-5909.2004 · Cited by 50
“Exogenous human 1:4 73 19 (26) 54 (74) 1:4–1:6 6 5 (83) 1 (17) 1:7–1:19 0 NA NA 1:20 12 11 (92) 1 (8)”
BackgroundHuman-Like Immune Responses in CD46 Transgenic Mice
Johansson, L., Rytkönen, A., Wan, H., Bergman, P., Plant, L., Agerberth, B., Hökfelt, T. G. M., & Jonsson, A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.433 · Cited by 49
“LPS-deficient FAM20 (lpxA mutant) does not cause disease in CD46 transgenic mice at equivalent doses (25).”
BackgroundInfluentialSelf-citationPro-inflammatory cytokines can act as intracellular modulators of commensal bacterial virulence
Mahdavi, J., Royer, P., Sjölinder, H., Azimi, S., Self, T. J., Stoof, J., Wheldon, L. M., Brännström, K., Wilson, R., Moreton, J., et al. (2013) · Open Biology · doi:10.1098/rsob.130048 · Cited by 48
“The interaction with human CD46 represents a critical step for the onset of bacterial meningitis [39].”
BackgroundSelf-citationThe Host-Pathogen Interactions and Epicellular Lifestyle of Neisseria meningitidis
Mikucki, A., McCluskey, N. R., & Kahler, C. M. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.862935 · Cited by 48
Vascular colonization by Neisseria meningitidis
Melican, K., & Duménil, G. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.10.008 · Cited by 48
Imaging of Disease Dynamics during Meningococcal Sepsis
Sjölinder, H., & Jonsson, A. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000241 · Cited by 48
“Since the PilC1 mutant were not found at the respiratory mucosa, but crossed the BBB, it is likely that the mechanisms by which N. meningitidis interacts with these two cellular barriers are different.”
BackgroundMethodSelf-citationSanders, M. S., van Well, G. T. J., Ouburg, S., Morré, S. A., & van Furth, A. M. (2011) · Genes and Immunity · doi:10.1038/gene.2011.20 · Cited by 47
“NM pili bind to CD46, a human cell surface protein, richly expressed at BMECs [77], promoting passage of the BBB in human CD46 transgenic mice [78].”
Backgroundde Souza, A. L., & Seguro, A. C. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47599-0 · Cited by 47
“, 2006); the CD46 receptor (Johansson et al., 2003); endotoxins (Brandtzaeg et al.”
BackgroundExperimental Meningococcal Sepsis in Congenic Transgenic Mice Expressing Human Transferrin
Szatanik, M., Hong, E., Ruckly, C., Ledroit, M., Giorgini, D., Jopek, K., Nicola, M.-A., Deghmane, A.-E., & Taha, M.-K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022210 · Cited by 42
“The integral analysis of bacteria-host interaction is hindered by the few available relevant animal models due to the restriction of Nm to human [3].”
BackgroundThe role of the complement system in CNS inflammatory diseases
Stahel, P. F., & Barnum, S. R. (2006) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2.3.445 · Cited by 44
Genetic Dissection of the Host Tropism of Human-Tropic Pathogens
Douam, F., Gaska, J. M., Winer, B. Y., Ding, Q., von Schaewen, M., & Ploß, A. (2015) · Annual Review of Genetics · doi:10.1146/annurev-genet-112414-054823 · Cited by 43
“meningitidis, either intraperitoneally or intranasally, leads to increased bacteremia in the blood as well as in the cerebrospinal fluids compared with infection of nontransgenic mice (59).”
BackgroundNeisseria gonorrhoeae infection causes a G1 arrest in human epithelial cells
Jones, A., Jonsson, A., & Aro, H. (2006) · The FASEB Journal · doi:10.1096/fj.06-6675com · Cited by 43
Self-citationRenauld-Mongénie, G., Poncet, D., Mignon, M., Fraysse, S., Chabanel, C., Danve, B., Krell, T., & Quentin-Millet, M.-J. (2004) · Infection and Immunity · doi:10.1128/iai.72.6.3461-3470.2004 · Cited by 29
Bai, X., & Borrow, R. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.116 · Cited by 42
Adenovirus serotype 35 vector-mediated transduction into human CD46-transgenic mice
Sakurai, F., Kawabata, K., Koizumi, N., Inoue, N., Okabe, M., Yamaguchi, T., Hayakawa, T., & Mizuguchi, H. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302749 · Cited by 42
Ricci, S., Grandgirard, D., Wenzel, M., Braccini, T., Salvatore, P., Oggioni, M. R., Leib, S. L., & Koedel, U. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0726-6 · Cited by 41
“Transgenic mice for human CD46 [28] or transferrin [29] have also been employed to overcome shortcomings of traditional systems.”
BackgroundKhairalla, A. S., Omer, S. A., Mahdavi, J., Aslam, A., Dufailu, O. A., Self, T. J., Jonsson, A., Geörg, M., Sjölinder, H., Royer, P., et al. (2015) · Cellular Microbiology · doi:10.1111/cmi.12417 · Cited by 40
Self-citationEnhanced Bacteremia in Human Factor H Transgenic Rats Infected by Neisseria meningitidis
Vu, D. M., Shaughnessy, J., Lewis, L. A., Ram, S., Rice, P. A., & Granoff, D. M. (2011) · Infection and Immunity · doi:10.1128/iai.05604-11 · Cited by 40
“Although human CD46 transgenic mice were more susceptible to developing meningococcal meningitis than control mice (15), and human transferrin transgenic mice (38) developed higher levels of meningococcal bacteremia than control mice that did not express the respective transgene, both of these transgenic models requir…”
BackgroundBiofilm formation by the human pathogen Neisseria meningitidis
Lappann, M., & Vogel, U. F. (2010) · Medical Microbiology and Immunology · doi:10.1007/s00430-010-0149-y · Cited by 40
“The next challenge will be to translate these Wndings into the perspective of host pathogen interaction using humanized transgenic animal models [37, 126] that might provide a true reXection of the natural interaction with the human”
BackgroundLi, Y., Zhang, Q., Winterbotham, M., Mowe, E. N., GORRINGE, A. R., & Tang, C. M. (2006) · Infection and Immunity · doi:10.1128/iai.01062-06 · Cited by 40
“presses an appropriate form of CD46 (27), the receptor”
BackgroundIdentification of Meningococcal Genes Necessary for Colonization of Human Upper Airway Tissue
Exley, R. M., Sim, R., Goodwin, L., Winterbotham, M., Schneider, M. C., Read, R. C., & Tang, C. M. (2008) · Infection and Immunity · doi:10.1128/iai.00968-08 · Cited by 40
“The advantage of using nasopharyngeal tissue is that it avoids the use of animal models which may lack human specific factors such as CD46 that are relevant for colonization (20).”
BackgroundKemper, C., & Atkinson, J. P. (2008) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-70523-9_3 · Cited by 39
Experimental disease models for the assessment of meningococcal vaccines
GORRINGE, A. R., Reddin, K. M., Funnell, S. G. P., Johansson, L., Rytkönen, A., & JONSSON, A. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.053 · Cited by 39
Self-citationCanova, C., Neal, J. W., & Gasque, P. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-22 · Cited by 39
“g Measles) are known to bind to several Cregs and so evading the host innate immune defense mechanisms [29,39-41].”
BackgroundLettiero, B., Andersen, A. J., Hunter, A. C., & Moghimi, S. M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.036 · Cited by 35
“Currently, a number of brain-specific nanoparticle (NP)- and supramolecular- . rights reserved. based approaches are being developed to induce disaggregation and eventual clearance of cerebral amyloid-β (Aβ), which in AD patients is deposited due to a shift in the Aβ equilibrium across the blood-brain barrier (BBB), l…”
InfluentialShinjyo, N., Kagaya, W., & Pekna, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.710390 · Cited by 34
Loss of Meningococcal PilU Delays Microcolony Formation and Attenuates Virulence In Vivo
Eriksson, J., Eriksson, O. S., & Jonsson, A. (2012) · Infection and Immunity · doi:10.1128/iai.06354-11 · Cited by 34
“The CD46 transgenic BL6 mouse strain used for in vivo studies expresses human CD46 in a human-like pattern and has been described previously (11, 12).”
BackgroundSelf-citationColicchio, R., Ricci, S., Lamberti, F., Pagliarulo, C., Pagliuca, C., Braione, V., Braccini, T., Talà, A., Montanaro, D., Tripodi, S. A., et al. (2009) · Infection and Immunity · doi:10.1128/iai.01424-08 · Cited by 34
“To overcome some shortcomings of traditional models, alternative strategies have also been explored (8), including the use of transgenic mice expressing human CD46 (18) or transferrin (60).”
MethodApicella, M. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00211-3 · Cited by 33
Lingappa, J. R., Dumitrescu, L. C., Zimmer, S. M., Lynfield, R., McNicholl, J. M., Messonnier, N. E., Whitney, C. G., & Crawford, D. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023413 · Cited by 32
CD46 Contributes to the Severity of Group A Streptococcal Infection
Lövkvist, L., Sjölinder, H., Wehelie, R., Aro, H., Norrby‐Teglund, A., Plant, L., & Jonsson, A. (2008) · Infection and Immunity · doi:10.1128/iai.00109-08 · Cited by 31
“These mice express CD46 in a human-like manner and elicit immune responses similar to that of humans as a consequence of bacterial attack (21, 22), suggesting that the mouse model is an adequate experimental in vivo system.”
BackgroundSelf-citationAsmat, T. M., Tenenbaum, T., Jonsson, A., Schwerk, C., & Schroten, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114474 · Cited by 30
Self-citationCD46 in Neisseria pathogenesis
Gill, D. B., & Atkinson, J. P. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.07.002 · Cited by 30
A Natural Mouse Model for Neisseria Colonization
Ma, M., Powell, D. A., Weyand, N. J., Rhodes, K. A., Rendón, M. A., Frelinger, J. A., & So, M. (2018) · Infection and Immunity · doi:10.1128/iai.00839-17 · Cited by 29
Lewis, L. A., Vu, D. M., Granoff, D. M., & Ram, S. (2014) · Infection and Immunity · doi:10.1128/iai.01517-14 · Cited by 28
“In mice, inocula greater than 106 CFU are required to cause bacteremia, and again investigators have tended to disproportionally use PorB2 isolates such as FAM20 (100, 101), NMB (102), LNP24198 (103), LNP8013, or 4243.”
BackgroundPathogenic Neisseria Hitchhike on the Uropod of Human Neutrophils
Söderholm, N., Vielfort, K., Hultenby, K. R., & Aro, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024353 · Cited by 27
“In addition, the non-piliated strain JB515 P2 (serogroup W135) [43] adhered to less than 5% of the PMNs counted (data not shown), as seen also for the non-piliated MS11 strain.”
BackgroundQuality control of vaccines-A journey from classical approach to 3Rs.
Suresh, K., Mahendra, P. S., Vijay, K. B., & Ramendra, P. P. (2018) · Microbiology Current Research · doi:10.4066/2591-8036.18-369 · Cited by 27
“Transgenic mice expressing human target receptors such as CD46 or CD66 have been developed by using genetic methods and used for measles virus or Neisseria infections [24,25].”
Method
Metadata
- Authors
- Johansson, L., Rytkönen, A., Bergman, P., Albiger, B., Källström, H., Hökfelt, T., Agerberth, B., Cattaneo, R., & Jonsson, A.-B.
- Affiliations
- Mayo Clinic (US)
- Microbiology and Tumor Biology Center, Nobels väg 16, Box 280, Karolinska Institutet, SE-171 77 Stockholm, Sweden. Department of Medical Biochemistry and Biophysics, Department of Cell and Molecular Biology, Department of Neuroscience, Karolinska Institutet, SE-171 77 Stockholm, Sweden. Swedish Institute for Infectious Disease Control, SE-171 82 Solna, Sweden. Molecular Medicine Program, Mayo Clinic, Guggenheim 1838, 200 First Street SW, Rochester, MN 55905, USA.
- Corresponding author
- Jonsson, Ann-Beth
- Venue
- Science
- Published
- 2003-07-18
- Volume
- 301
- Issue
- 5631
- Pages
- 373-375
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2092199147
- Cited by
- 182
- References
- 26
- Citations by year
- 2024: 4 · 2023: 3 · 2022: 2 · 2021: 3 · 2020: 6 · 2019: 3 · 2018: 2 · 2017: 4 · 2016: 9 · 2015: 8 · 2014: 11 · 2013: 9 · 2012: 9
- FWCI
- 11.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Keywords
- CD46, Neisseria meningitidis, meningococcal disease, bacterial pili, complement regulation, blood-brain barrier, transgenic mouse model, mucosal infection, meningitis, sepsis, vaccine development, pathogenesis
- MeSH terms
- Animals, Anti-Bacterial Agents, Blood-Brain Barrier, Cerebrospinal Fluid, Disease Models, Animal, Humans, Membrane Glycoproteins, Meningitis, Meningococcal, Meningococcal Infections, Mice, Inbred C57BL, Mice, Transgenic, Nasopharynx, Neisseria meningitidis, Fimbriae, Bacterial, Colony Count, Microbial, Antigens, CD, Bacteremia, Mice, Membrane Cofactor Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.